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INTRODUCTION
Adult neural progenitor cells or neu-
ral stem cells (NSCs) persist in the
adult human brain in two well-established
regions, the subventricular zone (SVZ)
and the subgranular zone (SGZ) of the
dentate gyrus. Newborn neurons have
been observed in the human SGZ in adults
and contribute to specific forms of mem-
ory encoding at least in rodents (Braun
and Jessberger, 2014). Neurogenesis from
the adult SVZ was primarily identified
in the olfactory bulb in rodents and was
shown to stop early in life in humans
despite the continuous presence of NSCs
(Sanai et al., 2011). However, a recent
study reports neurogenesis in the stria-
tum from the adult human SVZ (Ernst
et al., 2014). This finding highlights the
difference between rodents and humans
and the fact that some brain regions dis-
play an unexpected capacity for newborn
neuron migration and survival. The SVZ
is a prime region to consider for brain
repair considering that it spans the entire
cerebrum while the SGZ is limited to
the hippocampus. Other regions are now
known to contain NSCs or progenitor cells
such as the hypothalamus, but this will
not be discussed here. Several milestones
need to be achieved prior to considering
functional repair. These include, but may
not be limited to: (1) Understanding the
mechanisms leading to NSC quiescence
and loss with aging. Several mechanisms
are involved in the different regulatory
steps of NSC self-renewal and loss. We will
emphasize some of the mechanisms lead-
ing to NSC loss with aging. Once these
mechanisms are identified, we should be
able to amplify the pool of NSCs and
direct their differentiation. (2) Identifying
the molecules responsible for fate deter-
mination of NSCs and their daughter
cells to generate glia or neurons of dif-
ferent types, including interneurons and
long projection neurons. (3) Determining
the inhibitory molecules that make the
adult brain resistant to repair. Some
repair has been reported in the cortex of
rodents, but it is abortive possibly due
to an unfriendly environment. (4) Finally,
although we can genetically manipulate
NSCs in rodents, it is a different issue
in humans. Delivery systems need to be
improved. Each of this point is further
discussed below.
UNDERSTANDING THE MECHANISMS
LEADING TO ADULT NSC QUIESCENCE
AND LOSS WITH AGING
Significant amount of work has been
focused on understanding the signaling
molecules and pathways involved in the
regulation of NSC quiescence (Basak and
Taylor, 2009). For example, two major
players are the Notch and Wnt signal-
ing pathways. Most of the identified path-
ways are conserved between embryonic
and adult NSCs although some molec-
ular players may differ. They are also
conserved across NSC niches including
in the periphery (Fuchs et al., 2004).
Although a large repertoire of molecules
have been identified, some confusion
remains regarding the true molecular
identity of the dormant, quiescent and
activated (i.e., proliferative) NSCs. The
question why a dormant NSC becomes
activated remains unanswered. In others
terms, what are the molecules necessary
and sufficient to wake up NSCs? Whether
these molecules are the same for all NSCs
remain unclear.
In addition, an injury to the brain
may dramatically affect the activation state
of molecular pathways in NSCs as well
as their microenvironment. Very little is
known on how NSCs respond to injury in
terms of their molecular signature driving
them out of dormancy. To make matter
more complicated, every injury may not
alter NSCs in similar fashion. These ques-
tions need to be fully examined.
Aging is a natural phenomenon affect-
ing NSCs and their microenvironment
(van and Franklin, 2013). One clear out-
come of aging is a loss of NSCs and
thus reduction in neurogenesis. The extent
and mechanisms of NSC loss are likely
different in the SGZ and NSC (Shruster
et al., 2010). In the SGZ, NSCs termi-
nally differentiate into astrocytes (Encinas
et al., 2011). In the SVZ, there is a pro-
gressive loss of transit amplifying cells
with aging (Paliouras et al., 2012). At the
molecular level, one key player in aging
is the mammalian target of rapamycin
complex 1 (mTORC1) pathway, which
controls cap-dependent protein transla-
tion (Johnson et al., 2013). There are no
data for mTORC1 contribution to aging
in the SGZ. In the SVZ, mTORC1 has
been involved in the loss of NSC with
aging (Paliouras et al., 2012). In addi-
tion, activation of this pathway during
aging has been proposed to be involved in
the terminal differentiation of NSCs into
daughter cells, thus contributing to NSC
loss (Hartman et al., 2013). Thus, whether
small amount of the mTORC1 blocker,
rapamycin, could prevent progressive NSC
loss is to be examined. mTORC1 activity
increases with aging in other systems and
rapamycin has been shown to prolong life
of animals.
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IDENTIFYING THE MOLECULAR
MECHANISMS CONTROLLING FATE
DETERMINATION TO GENERATE EVERY
NEURON TYPE
Adult NSCs essentially generate neurons,
most specifically interneurons. In the SVZ,
they were shown to be genetically pre-
determined to generate specific subclasses
of olfactory interneurons (Merkle et al.,
2007). The genetic network involved in
this specificity remains to be identified.
In addition, identifying the molecular
program determining this fate restricted
genetic network needs to be examined ear-
lier during development. In other terms,
we will learn from studies focused on
the identification of the programs at play
in embryonic NSCs that determine their
restricted fate once adult NSCs.
With brain repair in mind, there is
a need to generate long range projec-
tion neurons and not just interneurons.
Progress needs to be made in our abili-
ties to reprogram adult NSCs to resemble
embryonic NSCs with broader fate deter-
mination. Novel reprogramming tech-
nologies are developed exponentially in
line with the discovery of induced pluripo-
tent stem cells. This technologies need to
be applied to adult NSCs in vitro and
in vivo.
DETERMINING THE INHIBITORY
MOLECULES MAKING THE ADULT
BRAIN RESISTANT TO REPAIR
Perhaps as a protective mechanism for
maintaining long-term memory, the adult
brain displays very limited repair despite
the presence of NSCs in the human
SVZ and the reported existence of cells
with neural progenitor property in the
parenchyma. The adult brain contains
repulsive cues (e.g., NOGO and similar
factors) and lack nurturing cues for NSC
and newborn neurons to survive and inte-
grate, thus providing a non-permissive
environment for neurogenesis. There is a
definite need for studies aimed at iden-
tifying the repulsive cues present in the
adult parenchyma preventing NSC and
immature neuron survival and integra-
tion in normal and injury conditions. In
addition, it will be important to compare
the molecular signature of different brain
regions that display different permissive-
ness to repair such as the striatum ver-
sus the cortex (Ernst et al., 2014). Large
molecular screens as well as hypothesis-
driven approaches could be taken to
address this issue.
One remaining major limitation is
access to human brain tissue. The human
brain is likely more resistant to repair
than the mouse brain. Efforts to develop
approaches to perform screen in human
tissue and identify factors preventing




Even if we address all of the issues
listed above, we are left with the task
of developing strategies to manipulate
cells in the human brains in the least
invasive way possible. So far, the best
strategy has been to use pharmacological
treatments in humans. However, repro-
gramming NSCs to generate new types of
neurons will require transferring DNA or
genetic material into cells. In the rodent
brain, such strategy is achieved in spe-
cific cell types using transgenic animals,
viral delivery, electroporation, nanopar-
ticle or exosomal delivery systems, and
to some extent cell-penetrating peptides.
Nanoparticle and exosomal strategies are
promising for humans. In particular, non-
invasive intra-nasal delivery is attrac-
tive and should be further explored.
For success in developing in vivo deliv-
ery systems in humans, biologists and
FIGURE 1 | Scattered plots illustrating the number of publications per year obtained in
Pubmed using the following two key words: adult neurogenesis (red) and long term
potentiation. Both fields display increases over time, but the adult neurogenesis field displays an
exponential increase starting in the late 1990’s while the long term potential field displays a linear
increase likely reflecting the increase in the number of scientists during this period.
bioengineers will need to exchange con-
cepts and work together.
CONCLUSION
Despite the hurdles outlined above and
the length of time that will be required
for achieving brain repair and cognitive
enhancement, we cannot fail to pursue
our investigations of the four fields out-
lined above. In the past decade, there has
been an exponential increase in studies
related to the field of “adult neurogenesis.”
This is outlined in Figure 1 following a
search in PubMed with this keyword com-
pared to a search with “long term poten-
tiation,” which outlines the growth of the
neuroscience field. Although there is an
apparent stabilization of the growth of the
adult neurogenesis field since 2011, this
likely reflects the expansion of the field
and thus the need to use additional key-
words in our search such as adult NSC,
repair in the adult brain, adult SVZ or
SGZ. This is my hope and belief that
despite economic recession affecting sci-
entific growth the number of labs study-
ing adult neurogenesis and NSCs is still
increasing.
Overall, the present energetic study of
stem cell biology and brain delivery sys-
tems will provide a better understand-
ing of brain development, endogenous
responses to injuries, and additional ther-
apeutic approaches for brain repair, and
hold great promise for broadening the
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therapeutic options available for main-
taining and restoring cognition following
brain injury and during neurodegenera-
tive diseases. Finally, validating that find-
ings obtained in animal models apply to
humans is a must. While some molecules
may be the same, the pathways may be dif-
ferent or act differently and this needs to
be validated in human adult NSCs prior to
trying to repair the human brain.
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